% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 8

Loading Chart...

6 inventors (with patents filed for the assignee):

James Callaway (3 out of 13 patents)

John Wahren (3 out of 7 patents)

Karin Ekberg (2 out of 3 patents)

4. Anders Carlsson (1 out of 22 patents)

5. Sheri Barrack (1 out of 3 patents)

6. Michelle Mazzoni (1 out of 3 patents)

7. John Wahren (0 patent)

4 patents: Sort by Forward Citations

1. 8927489 - Sustained release preparation of pro-insulin C-peptide (2015-01-06),

2. 8927488 - Pegylated C-peptide (2015-01-06),

3. 8410049 - Methods and kits for preventing hypoglycemia (2013-04-02),

4. 7855177 - Methods and kits for preventing hypoglycemia (2010-12-21),

Company Overview

Cebix Incorporated is a biotechnology company focused on developing innovative therapies for neurological disorders. With a team of experienced scientists and a dedication to research and development, Cebix is at the forefront of cutting-edge treatments for conditions such as Alzheimer's disease and Parkinson's disease. Through strategic partnerships and a commitment to improving patient outcomes, Cebix is driving advancements in the field of neurology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#1,006 in San Diego, CA

#14,041 in California

#60,597 in US

San Diego, CA, United States of America

Cebix Incorporated

Forward Citations = 8

6 inventors:

James Callaway (3 out of 13 patents)

John Wahren (3 out of 7 patents)

Karin Ekberg (2 out of 3 patents)

4. Anders Carlsson (1 out of 22 patents)

5. Sheri Barrack (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cebix Incorporated. Retrieved from https://idiyas.com/company/cebix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]